1. Enzymatic production of key intermediate of gabapentin by recombinant amidase from Pantoea sp. with high ratio of substrate to biocatalyst
- Author
-
Zhe-Ming Wu, Jian-Qiang Jin, Xu Ding, Yu-Guo Zheng, and Ren-Chao Zheng
- Subjects
0301 basic medicine ,010405 organic chemistry ,Chemistry ,Substrate (chemistry) ,Bioengineering ,01 natural sciences ,Applied Microbiology and Biotechnology ,Biochemistry ,0104 chemical sciences ,Amidase ,Catalysis ,03 medical and health sciences ,Hydrolysis ,030104 developmental biology ,Product inhibition ,Enzymatic hydrolysis ,Organic chemistry ,Enzyme kinetics ,Bioprocess - Abstract
1-Cyanocyclohexaneacetic acid is the key intermediate of gabapentin. A novel bioprocess catalyzed by amidase was developed for efficient production of 1-cyanocyclohexaneacetic acid from 1-cyanocyclohexaneacetamide, which can be prepared with high efficiency by nitrile hydratase-catalyzed regioselective hydration of 1-cyanocyclohexaneacetonitrile. Kinetic analysis and molecular docking of three recombinant amidase demonstrated that amidase (Pa-Ami) from Pantoea sp. was the most robust biocatalyst for hydrolysis of 1-cyanocyclohexaneacetamide with the kcat/Km value of 208.2 ± 16.2 mM−1 s−1. Some key parameters of the bioprocess, such as substrate loading, catalyst loading and product inhibition, were investigated. Enzymatic hydrolysis of 80 g/L of 1-cyanocyclohexaneacetamide was completed within 20 min using 1 g/L wet whole cells of recombinant Escherichia coli BL21, leading to high ratio of substrate to catalyst (S/C-ratio, 80) and high space-time yield (5794.7 gproduct L−1 d−1). These encouraging results indicated the great potential of Pa-Ami in practical production of gabapentin.
- Published
- 2016
- Full Text
- View/download PDF